SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* MUSICK JAMES R (Last) (First) (Middle) 3200 CHERRY CREEK DRIVE SOUTH, SUITE 720 (Street) DENVER, CO 80209 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 11/11/2022	3. Issuer Name and Ticker or Trading Symbol Vitro Biopharma, Inc. [ NONE ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner X Officer (give title below) Other (specify below) Chief Science Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,340,498	D
Common Stock	22,727,635	I	By Trust(1)
Common Stock	2,956,849	I	By Spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	(2)	04/30/2028	Common Stock	4,300,000	$0.05	D
Employee Stock Option (Right to Buy)	(3)	11/30/2030	Common Stock	1,000,000	$0.5	D

1. Name and Address of Reporting Person* MUSICK JAMES R (Last) (First) (Middle) 3200 CHERRY CREEK DRIVE SOUTH, SUITE 720 (Street) DENVER, CO 80209 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director X 10% Owner X Officer (give title below) Other (specify below) Chief Science Officer

1. Name and Address of Reporting Person* James R Musick Trust (Last) (First) (Middle) 3200 CHERRY CREEK DRIVE SOUTH, SUITE 720 (Street) DENVER, CO 80209 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. Shares are held by the James R. Musick Trust, of which James R. Musick serves as the sole trustee and beneficiary.

2. The option became exercisable as to (i) 860,000 shares on May 1, 2018, (ii) 860,000 shares on May 1, 2019, (iii) 860,000 shares on May 1, 2020, (iv) 860,000 shares on May 1, 2021, and (v) 860,000 shares on May 1, 2022.

3. The option became exercisable as to 200,000 shares on November 30, 2021, and will become exercisable as to (i) 200,000 shares on November 30, 2022, (ii) 200,000 shares on November 30, 2023, (iii) 200,000 shares on November 30, 2024 and (iv) 200,000 shares on November 30, 2025.

	/s/ James R. Musick	11/14/2022
	/s/ James R. Musick Trust by James R. Musick as Trustee	11/14/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.